skip to Main Content
22-25 Jun 2021

Topic: All topics

Organised by: EASL

Location: Amsterdam RAI | Amsterdam, Netherlands

Meeting Type: EASL International Liver Congress™


The International Liver Congress™ 2021:
a multidisciplinary approach to beating liver disease together

A message from EASL Secretary General

In 2020, with the COVID-19 pandemic, medical associations like ours took their flagship onsite events offline, bringing their communities together digitally and keeping vibrant scientific exchange alive. EASL reacted with agility, holding The Digital ILC 2020 online as a lively, immersive, three-day event.

In 2021, we will be bringing the members of our community together again in person, around the same table, to explore how to tackle liver disease with a multidisciplinary approach.

Attendees will hear the latest in epidemiological and real-world data on liver disease and gain a deeper understanding of the underlying mechanisms. Leading clinicians and researchers in the field will talk about daily interactions with patients, to help with or even reverse liver disease, and updates on treatment options. The congress will also update attendees on EASL’s important policy and advocacy work, providing evidence and support to governments and international organisations implementing laws and policies that promote liver health.

EASL is continuing to forge new alliances with diabetes, obesity, and oncology associations to enhance our educational programming. Through 2020, we promoted the year of the nurse and our nurses and allied health professionals (AHPs) task force, at the heart of multidisciplinary practice, will have dedicated sessions at ILC 2021 to share their expertise.

Whatever your role, ILC 2021 will involve you in EASL’s mission to improve liver heath and support you in doing your part.

We look forward to welcoming you to The International Liver Congress™ 2021!

Prof. Philip Newsome
EASL Secretary General

Sponsorship opportunities

Get in touch with us to discuss corporate investment opportunities and strategies for ILC 2021.


Stéphane Dazet

Head of Business Development & Events

Tel: +41 22 807 29 86


Alexis Schwery

Corporate Relations & Fundraising Coordinator

Tel: +41 22 807 03 68

Laudina Asomaning

Business Development & Events Associate

Tel: +41 77 981 68 59

Important Notice

Be aware that there are websites, companies, and individuals who falsely claim or imply that they are partners of the annual EASL meeting, The Digital International Liver Congress™.
EASL does not accept any responsibility for bookings made via unofficial websites/agencies or any monies lost as a result. www.ilc-congress.eu is the official and only Congress website.

Topics to be covered

Key sessions

One-day courses:
1. Postgraduate course: Lifestyle and the liver
2. Basic science seminar: Artificial intelligence and omics data in hepatology

State of the Art lectures:
1. Immunotherapy in HCC
2. Immunometabolism for hepatologists?
3. Steps towards cirrhosis – and back?

General hepatology

Key topics addressed

1. Advances in basic science and regenerative medicine
2. Application of computer science in hepatology: the role of big data processing for integrating omics data, and artificial intelligence for improving disease risk stratification and image interpretation
3. Update on immunological liver diseases and liver transplantation
4. Update on the most significant advances relevant to all hepatologists over the past year

Metabolic, alcohol and toxicity

Key topics addressed:

1. Role of lifestyle in the pathogenesis of liver disease – obesity and excess alcohol as main aetiological factors
2. New screening and case-finding strategies for liver disease in the population and novel biomarkers
3. Emerging mechanisms of disease, including the role of the gut-liver axis and inflammatory pathways
4. Advancements in the development of new treatments and therapeutic approaches for non-alcoholic fatty liver disease

Cholestasis and autoimmune

Key topics addressed

1. Clinical considerations from itch and fatigue, to bone and skin disorders in cholestasis
2. A pros and cons session will also address whether or not to use Fxr agonists in cholangiopathies
3. A Grand Rounds session will tackle the discussion on managing patients with sclerosing cholangitis
4. A deeper understanding of the genetic and cellular mechanisms leading to cholestasis is needed; and will be the focus of both a Symposium and a Meet the Experts sessions

Cirrhosis and complications

Key topics addressed:

1. Liver vessels changes as drivers of liver disease progression
2. Management of ascites acute kidney and its complications
3. Management of oesophageal varices in 2021
4. New challenges in the management of vascular liver diseases

Viral hepatitis

Key topics addressed:

1. The pipeline to cure chronic hepatitis B
2. The road towards global HCV elimination
3. New treatment options for chronic hepatitis D are on the horizon
4. Understanding the pathogenesis of hepatitis E virus infection and developing concepts to cure chronic hepatitis E

Liver tumours

Key topics addressed:

1. Knowledge in the liver carcinogenesis mechanisms is growing
2. Radiology and pathology tools for liver cancer diagnosis
3. Management of special populations
4. Immunotherapy in liver cancer

Get notified

To receive the latest news about ILC 2021, please sign up for the dedicated newsletter.

An application has been made for CME accreditation of this event.

Key Deadlines

  • 06 Oct, 2020 - 02 Feb, 2021

    Abstract submission

  • 06 Oct, 2020 - 22 Mar, 2021

    Registration, early fees deadline

  • 01 Apr, 2021

    Abstract submitter notification

  • 20 - 29 Apr, 2021

    Late-breaker abstract submission

  • 18 May, 2021

    Late-breaker abstract submission notification

RAI, Amsterdam, The Netherlands

Back To Top